PCSK9 inhibitors in clinical practice: Expectations and reality

被引：33

作者：

Reiner, Zeljko ^{[1
]}

机构：

[1] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Med, Dept Internal Med, Kispaticeva 12, Zagreb 10000, Croatia

来源：

ATHEROSCLEROSIS | 2018年 / 270卷

关键词：

PCSK9; inhibitors; LDL-cholesterol; Familial hypercholesterolaemia; Statin intolerance; Evolocumab; Alirocumab; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; PREVENTION; MANAGEMENT; THERAPY;

D O I：

10.1016/j.atherosclerosis.2018.01.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：187 / 188

页数：2

共 15 条

[1] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].

Catapano, Alberico L. ;

Graham, Ian ;

De Backer, Guy ;

Wiklund, Olov ;

Chapman, M. John ;

Drexel, Heinz ;

Hoes, Arno W. ;

Jennings, Catriona S. ;

Landmesser, Ulf ;

Pedersen, Terje R. ;

Reiner, Zeljko ;

Riccardi, Gabriele ;

Taskinen, Marja-Riita ;

Tokgozoglu, Lale ;

Verschuren, W. M. Monique ;

Vlachopoulos, Charalambos ;

Wood, David A. ;

Luis Zamorano, Jose .

ATHEROSCLEROSIS, 2016, 253 :281-344

[2]

Huang Q, 2016, AM HEALTH DRUG BENEF, V9, P434

[3]

Mallya U.G., 2017, PHARMACOECONOMICS

[4] Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors [J].

Pecin, Ivan ;

Hartgers, Merel L. ;

Hovingh, G. Kees ;

Dent, Ricardo ;

Reiner, Zeljko .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (13) :1383-1401

[5] Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries - Findings from the EUROASPIRE IV survey [J].

Reiner, Z. ;

De Backer, G. ;

Fras, Z. ;

Kotseva, K. ;

Tokgozoglu, L. ;

Wood, D. ;

De Bacquer, D. .

ATHEROSCLEROSIS, 2016, 246 :243-250

[6] Resistance and intolerance to statins [J].

Reiner, Z. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (10) :1057-1066

[7] PCSK9 inhibitors - past, present and future [J].

Reiner, Zeljko .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) :1517-1521

[8] Management of patients with familial hypercholesterolaemia [J].

Reiner, Zeljko .

NATURE REVIEWS CARDIOLOGY, 2015, 12 (10) :565-575

[9] Statins in the primary prevention of cardiovascular disease [J].

Reiner, Zeljko .

NATURE REVIEWS CARDIOLOGY, 2013, 10 (08) :453-464

[10] Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel [J].

Santos, Raul D. ;

Gidding, Samuel S. ;

Hegele, Robert A. ;

Cuchel, Marina A. ;

Barter, Philip J. ;

Watts, Gerald F. ;

Baum, Seth J. ;

Catapano, Alberico L. ;

Chapman, M. John ;

Defesche, Joep C. ;

Folco, Emanuela ;

Freiberger, Tomas ;

Genest, Jacques ;

Hovingh, G. Kees ;

Harada-Shiba, Mariko ;

Humphries, Steve E. ;

Jackson, Ann S. ;

Mata, Pedro ;

Moriarty, Patrick M. ;

Raal, Frederick J. ;

Al-Rasadi, Khalid ;

Ray, Kausik K. ;

Reiner, Zelijko ;

Sijbrands, Eric J. G. ;

Yamashita, Shizuya .

LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (10) :850-861

← 1 2 →